about
A perspective on sirtuins in the metabolic syndrome.The dipeptidyl peptidase-4 inhibitor saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patientsAge-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence.The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing.A perspective on NETosis in diabetes and cardiometabolic disorders.NETosis is induced by high glucose and associated with type 2 diabetes.Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease.Diabetes Limits Stem Cell Mobilization Following G-CSF but Not PlerixaforEndothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxiaTechnical notes on endothelial progenitor cells: ways to escape from the knowledge plateau.Effects of androgens on endothelial progenitor cells in vitro and in vivo.Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clockEffects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trialCirculating smooth muscle progenitors and atherosclerosis.Endothelial progenitor cells in diabetes mellitus.Restoring stem cell mobilization to promote vascular repair in diabetes.p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans.Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1.Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence.Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes.DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes.Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients.Generation and validation of novel adeno-associated viral vectors for the analysis of Ca2+ homeostasis in motor neurons.NETosis Delays Diabetic Wound Healing in Mice and Humans.Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients.NAD(+)-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis.Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M.Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes.Erratum to "Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock" [Mol Metab 3 (2014) 29-41].Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients.Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells.Selective estrogen receptor-alpha agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action.An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy.Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes.Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens.Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism.Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression.Diabetes modifies the relationships among carotid plaque calcification, composition and inflammation.Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.
P50
Q30372068-3355847B-547C-451E-A1B6-4A8B408FEE59Q33662677-5565F907-AE77-45DD-B8F0-49C665269F5FQ33773474-2C3AFF01-E565-48E5-9BC6-71567A9EDB30Q33932817-3E534B48-1984-4235-9DAB-A5C3DA7400D8Q34082896-A8864192-A83F-4E50-9955-BC95DBD99F93Q34507024-F511570F-9218-41C6-BA3E-D3BD6BF9ADC5Q35410924-61B6BFC2-F96E-49CB-9E85-5FCE733B1814Q35821434-6AAD190E-2C9C-4698-B2CD-9602035D3E92Q35881779-8C18AC0F-9510-4BE3-A213-73751C376F66Q36234999-7E6FF02E-58C8-46BF-A092-ADF90D96356DQ37076991-640B969C-E0BF-4888-86E4-D2BA8AAC98ACQ37434313-F97ECB69-9AE8-40BE-B897-963E70725586Q37594450-D9B60057-E0A6-4AE6-A01E-DA01834F4510Q37736727-DF89A7A5-D86E-4E01-BA1F-E5360DCFBA52Q37844999-88E717FB-3122-47C9-916A-D503C5038F1BQ38001402-80E0D221-B7B5-4B86-8328-11453B1627E6Q38078140-2117544F-BE96-4841-908A-A3DBDA252239Q38297938-4ABE24F1-EC13-4EAB-890C-ECB369F0C342Q38310944-4A37FDF5-C6FA-4FFC-8F83-306E4283A4F8Q38562804-AAAA5C60-B89B-4FDC-B858-43B9A7B8A933Q38843000-54AB2940-CE38-4B3C-97A2-F351337EC45FQ38969169-1B320E42-CE02-40F5-885C-190B827FDBDFQ39034928-7FE271E4-4867-4F19-B678-324043372A0CQ40106935-1B2AEF3B-612A-4311-8171-30C9E3B2E61EQ40133978-353B306E-3096-494C-AD09-B711ECD9E668Q40975241-233E19E6-5840-41EC-A3DF-42780BF0171EQ41088828-EB9342E2-CD57-4381-8B77-4093515C8ECBQ41169174-9A34B8C0-2D94-4E64-823D-35135E8ACF9BQ41553791-7B60A6CD-937B-49C3-875B-0FC50829ADA6Q42582540-B6E5023B-A715-43AF-A36E-58F6EE123B5CQ42790819-70017ABC-9532-4B92-982B-F9EF1E265C41Q43127805-E9C5F5F8-8F54-4B6F-8A48-6085F474A297Q43142704-336568B6-7F47-4681-8C96-9E1785950D92Q45267642-22399438-9C7E-4DFA-A239-D33CAF9B3A10Q45805924-520BBD80-50FE-49A8-BA1D-B67E6DD00EBDQ46752443-726479A2-4B5E-4D8B-A2EB-01D19E837FB3Q46966126-2EFF3432-10E9-4DAC-94E8-8FC0521D4156Q48719325-C08CAB42-5976-4837-8B3C-972AFBF20FBDQ50442354-93817FEB-87A4-456F-951B-2AD6D49A8380Q51292103-16868782-D65A-4122-9B7A-6EF3CB16A93E
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Mattia Albiero
@ast
Mattia Albiero
@en
Mattia Albiero
@es
Mattia Albiero
@nl
Mattia Albiero
@sl
type
label
Mattia Albiero
@ast
Mattia Albiero
@en
Mattia Albiero
@es
Mattia Albiero
@nl
Mattia Albiero
@sl
prefLabel
Mattia Albiero
@ast
Mattia Albiero
@en
Mattia Albiero
@es
Mattia Albiero
@nl
Mattia Albiero
@sl
P214
P1053
J-4145-2012
P106
P1153
23007903100
P21
P214
P31
P3829
P3835
mattia-albiero
P396
IT\ICCU\CFIV\269251
P496
0000-0003-4142-9738
P569
1981-01-01T00:00:00Z
P7859
viaf-307342539